Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sean Hennessy

Showing results (221-230 of 237) with videos related to

Pageof 24
Sort By:
British Journal of Clinical Pharmacology|May 13, 2022
Skeletal muscle relaxant drug-drug-drug interactions and unintentional traumatic injury: Screening to detect three-way drug interaction signalsCheng Chen, Sean Hennessy, Colleen M Brensinger, et al.
Journal of Psychiatric Research|May 8, 2022
Population-based signals of benzodiazepine drug interactions associated with unintentional traumatic injuryThanh Phuong Pham Nguyen, Samantha E Soprano, Sean Hennessy, et al.
BMC Pharmacology & Toxicology|April 19, 2015
Determinants of saxagliptin use among patients with type 2 diabetes mellitus treated with oral anti-diabetic drugsM Elle Saine, Dena M Carbonari, Craig W Newcomb, et al.
Epidemiology (Cambridge, Mass.)|July 7, 2017
Sentinel Modular Program for Propensity Score-Matched Cohort Analyses: Application to Glyburide, Glipizide, and Serious HypoglycemiaMeijia Zhou, Shirley V Wang, Charles E Leonard, et al.
Pharmacoepidemiology and Drug Safety|March 14, 2018
Evaluation of the US Food and Drug Administration sentinel analysis tools in confirming previously observed drug-outcome associations: The case of clindamycin and Clostridium difficile infectionRyan M Carnahan, Jennifer L Kuntz, Shirley V Wang, et al.
CNS Drugs|March 6, 2022
Signals of Muscle Relaxant Drug Interactions Associated with Unintentional Traumatic Injury: A Population-Based Screening StudyGhadeer K Dawwas, Sean Hennessy, Colleen M Brensinger, et al.
Clinical Pharmacology and Therapeutics|February 9, 2021
Population-Based Signals of Antidepressant Drug Interactions Associated With Unintentional Traumatic InjuryCharles E Leonard, Colleen M Brensinger, Emily K Acton, et al.
Journal of the American Geriatrics Society|November 28, 2024
Defining key deprescribing measures from electronic health data: A multisite data harmonization projectSascha Dublin, Ladia Albertson-Junkans, Thanh Phuong Pham Nguyen, et al.
Pharmacoepidemiology and Drug Safety|December 11, 2024
Hepatotoxicity Score: A New Method to Adjust for Use of Potentially Hepatotoxic Medications by Chronic Liver Disease StatusVincent Lo Re, Craig W Newcomb, Dean M Carbonari, et al.
JAMA Internal Medicine|June 24, 2024
Severe Acute Liver Injury After Hepatotoxic Medication Initiation in Real-World DataJessie Torgersen, Alyssa K Mezochow, Craig W Newcomb, et al.
Pageof 24

Showing results (221-230 of 237) with videos related to

Sort By:
Pageof 24
British Journal of Clinical Pharmacology|May 13, 2022
Skeletal muscle relaxant drug-drug-drug interactions and unintentional traumatic injury: Screening to detect three-way drug interaction signalsCheng Chen, Sean Hennessy, Colleen M Brensinger, et al.
Journal of Psychiatric Research|May 8, 2022
Population-based signals of benzodiazepine drug interactions associated with unintentional traumatic injuryThanh Phuong Pham Nguyen, Samantha E Soprano, Sean Hennessy, et al.
BMC Pharmacology & Toxicology|April 19, 2015
Determinants of saxagliptin use among patients with type 2 diabetes mellitus treated with oral anti-diabetic drugsM Elle Saine, Dena M Carbonari, Craig W Newcomb, et al.
Epidemiology (Cambridge, Mass.)|July 7, 2017
Sentinel Modular Program for Propensity Score-Matched Cohort Analyses: Application to Glyburide, Glipizide, and Serious HypoglycemiaMeijia Zhou, Shirley V Wang, Charles E Leonard, et al.
Pharmacoepidemiology and Drug Safety|March 14, 2018
Evaluation of the US Food and Drug Administration sentinel analysis tools in confirming previously observed drug-outcome associations: The case of clindamycin and Clostridium difficile infectionRyan M Carnahan, Jennifer L Kuntz, Shirley V Wang, et al.
CNS Drugs|March 6, 2022
Signals of Muscle Relaxant Drug Interactions Associated with Unintentional Traumatic Injury: A Population-Based Screening StudyGhadeer K Dawwas, Sean Hennessy, Colleen M Brensinger, et al.
Clinical Pharmacology and Therapeutics|February 9, 2021
Population-Based Signals of Antidepressant Drug Interactions Associated With Unintentional Traumatic InjuryCharles E Leonard, Colleen M Brensinger, Emily K Acton, et al.
Journal of the American Geriatrics Society|November 28, 2024
Defining key deprescribing measures from electronic health data: A multisite data harmonization projectSascha Dublin, Ladia Albertson-Junkans, Thanh Phuong Pham Nguyen, et al.
Pharmacoepidemiology and Drug Safety|December 11, 2024
Hepatotoxicity Score: A New Method to Adjust for Use of Potentially Hepatotoxic Medications by Chronic Liver Disease StatusVincent Lo Re, Craig W Newcomb, Dean M Carbonari, et al.
JAMA Internal Medicine|June 24, 2024
Severe Acute Liver Injury After Hepatotoxic Medication Initiation in Real-World DataJessie Torgersen, Alyssa K Mezochow, Craig W Newcomb, et al.
Pageof 24